In-silico Studies of Heterocyclic Benzoxazole Derivatives as an Anticancer Agent: Molecular Docking, 2D and 3D QSAR . Int. J. Pharm. Sci. Drug Res. [Internet]. 2023 Nov. 30 [cited 2025 Sep. 22];15(6):780-8. Available from: https://ijpsdronline.com/index.php/journal/article/view/8073